Evidence map›Paper›PMID 39086596›Full record

ArticleArtery research2024

Unified Language for Knowledge Dissemination: The Vascular Ageing Glossary, an Initiative by VascAgeNet.

Elisabetta Bianchini, Rachel E Climie, Christopher Clemens Mayer, Maria Raffaella Martina, Manasi Nandi, Arno Schmidt-Trucksäss, Patrick Segers, Chloe Park, Giacomo Pucci, Dimitrios Terentes-Printzios and 2 more

Abstract read
In one paragraph

Article in Artery research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elisabetta BianchiniInstitute of Clinical Physiology (IFC), National Research Council (CNR), Pisa, Italy.
Rachel E ClimieMenzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart, 7000 Australia.
Christopher Clemens MayerCenter for Health and Bioresources, Medical Signal Analysis, AIT Austrian Institute of Technology GmbH, Giefinggasse 4, 1210 Vienna, Austria.
Maria Raffaella MartinaInstitute of Clinical Physiology (IFC), National Research Council (CNR), Pisa, Italy.ORCID 0000-0003-2489-8639
Manasi NandiSchool of Cancer and Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, 150 Stamford Street, London, SE19NH UK.
Arno Schmidt-TrucksässDivision of Sport and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel, Grosse Allee 6, 4052 Basel, Switzerland.
Patrick SegersInstitute of Biomedical Engineering and Technology, Ghent University, C. Heymanslaan 10, 9000 Ghent, Belgium.
Chloe ParkMRC Unit for Lifelong Health and Ageing at UCL, UCL, London, UK.
Giacomo PucciUnit of Internal Medicine, Department of Medicine and Surgery, Santa Maria Terni Hospital, University of Perugia, Terni, Italy.
Dimitrios Terentes-PrintziosFirst Department of Cardiology, National and Kapodistrian University of Athens, Medical School, Hippokration Hospital, Athens, Greece.
Peter H CharltonStrangeways Research Laboratory, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN UK.
for VascAgeNet

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: In general, a terminology shared and agreed by different stakeholders is important to facilitate communication and cooperation. This holds true in the field of vascular ageing for the benefit of global cardiovascular health. The need to promote a common language and understanding across this area was recognised by VascAgeNet, a collaborative network with relevant and diverse expertise in the vascular ageing field, supported by the European Cooperation in Science and Technology. To contribute to the spread of unified terms in the vascular ageing field, a glossary was created by VascAgeNet and this paper describes the systematic process used for its development. Methods: An initial list of terms and preliminary definitions were collated from the network. A dedicated team was created to design the glossary development process, to facilitate its implementation and to maximise outreach and dissemination. The key steps of the process were to determine: (1) the target audience; (2) a list of priority terms; (3) a template structure for definitions; (4) methods for collecting feedback and (5) the dissemination plan. Results: An implementation strategy was provided for each key step and shared within the network; main decisions were agreed by all members of the glossary team. Small groups of definitions were released on a regular basis within a pilot phase including 19 terms (status: 05.09.2023) that were published openly at https://vascagenet.eu/official-glossary. Conclusions: The strategy for creating the first Vascular Ageing Glossary has been successfully designed and developed within VascAgeNet. A pilot phase covering the first publicly available terms was completed. The glossary is a living document, available to the scientific community, which aims to unify the vascular ageing language. Supplementary Information: The online version contains supplementary material available at 10.1007/s44200-023-00041-5.

Indexed as

DisseminationGlossaryVascular ageing

Identifiers

PMID39086596
PMCPMC11286687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.